期刊文献+

肾上腺髓质素与肺动脉高压 被引量:4

原文传递
导出
摘要 肺动脉高压是一种严重的病理状态,目前尚无满意治疗手段.肾上腺髓质素作为一种新发现的血管活性肽,与肺动脉高压关系密切;心胸血管内外科利用其血管扩张性及多种生物活性可降低平均肺动脉压(MPAP)和肺血管阻力(PVR),减轻右心室肥厚,理论上应成为治疗肺动脉高压的一种较理想的手段.
出处 《中华胸心血管外科杂志》 CSCD 北大核心 2005年第6期381-382,共2页 Chinese Journal of Thoracic and Cardiovascular Surgery
  • 相关文献

参考文献19

  • 1Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun, 1993,192:553-560.
  • 2Westphal M, Booke M, Dinh-Xuan AT. Adrenomedullin: a smart road from pheochromocytoma to treatment of pulmonary hypertension. Eur Respir J, 2004,24:518-520.
  • 3Marutsuka K, Hatakeyama K, Sato Y. Immunohistological localization and possible functions of adrenomedullin. Hypertens Res,2003,26:S33-S40.
  • 4Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev, 2000,21:138-167.
  • 5Beltowski J, Jamroz A. Adrenomedullin-what do we know 10 years since its discovery? Pol J Pharmacol, 2004,56:5-27.
  • 6Nagaya N, Kangawa K. Adrenomedullin in the treatment of pulmonary hypertension. Pept, 2004,25:2013-2018.
  • 7Vijay P, Brown WJ, Sharp TG. Adrenomedullin reduces the risk for pulmonary hypertension in rats. Am J Hyperten,1999,12:205.
  • 8Horio T, Kohno M, Kano H, et al. Adrenomedullin as a novel anti-migration factor of vascular smooth muscle cells. Circ Res,1995,77: 660-664.
  • 9Vijay P, Brown WJ, Sharp TG et al. Adrenomedullin in patients at high risk for pulmonary hypertension. Ann Thorac Surg,1998,66:500-504.
  • 10Yoshihara F, Nishikimi T,Horio T, et al. Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline. Eur J Pharmacol,1998, 355:33-39.

同被引文献56

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部